KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Assets (2016 - 2025)

Historic Assets for Pfizer (PFE) over the last 17 years, with Q3 2025 value amounting to $209.0 billion.

  • Pfizer's Assets fell 477.32% to $209.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $209.0 billion, marking a year-over-year decrease of 477.32%. This contributed to the annual value of $213.4 billion for FY2024, which is 599.3% down from last year.
  • As of Q3 2025, Pfizer's Assets stood at $209.0 billion, which was down 477.32% from $206.1 billion recorded in Q2 2025.
  • In the past 5 years, Pfizer's Assets registered a high of $227.0 billion during Q4 2023, and its lowest value of $41.1 billion during Q4 2022.
  • Over the past 5 years, Pfizer's median Assets value was $206.1 billion (recorded in 2025), while the average stood at $185.6 billion.
  • In the last 5 years, Pfizer's Assets tumbled by 1121.83% in 2022 and then soared by 42269.49% in 2023.
  • Over the past 5 years, Pfizer's Assets (Quarter) stood at $181.5 billion in 2021, then grew by 8.67% to $197.2 billion in 2022, then grew by 15.11% to $227.0 billion in 2023, then dropped by 5.99% to $213.4 billion in 2024, then fell by 2.06% to $209.0 billion in 2025.
  • Its Assets was $209.0 billion in Q3 2025, compared to $206.1 billion in Q2 2025 and $208.0 billion in Q1 2025.